Notice: This company has been marked as potentially delisted and may not be actively trading. Zafgen (ZFGN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends ZFGN vs. NUVB, AVBP, ETNB, CAPR, LQDA, EOLS, RAPP, ABCL, PCRX, and PLRXShould you be buying Zafgen stock or one of its competitors? The main competitors of Zafgen include Nuvation Bio (NUVB), ArriVent BioPharma (AVBP), 89bio (ETNB), Capricor Therapeutics (CAPR), Liquidia (LQDA), Evolus (EOLS), Rapport Therapeutics (RAPP), AbCellera Biologics (ABCL), Pacira BioSciences (PCRX), and Pliant Therapeutics (PLRX). These companies are all part of the "medical" sector. Zafgen vs. Nuvation Bio ArriVent BioPharma 89bio Capricor Therapeutics Liquidia Evolus Rapport Therapeutics AbCellera Biologics Pacira BioSciences Pliant Therapeutics Zafgen (NASDAQ:ZFGN) and Nuvation Bio (NYSE:NUVB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, media sentiment, community ranking, valuation, earnings, institutional ownership and dividends. Do analysts rate ZFGN or NUVB? Nuvation Bio has a consensus price target of $6.60, indicating a potential upside of 144.44%. Given Nuvation Bio's stronger consensus rating and higher probable upside, analysts plainly believe Nuvation Bio is more favorable than Zafgen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zafgen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Nuvation Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to ZFGN or NUVB? In the previous week, Nuvation Bio had 2 more articles in the media than Zafgen. MarketBeat recorded 2 mentions for Nuvation Bio and 0 mentions for Zafgen. Nuvation Bio's average media sentiment score of 0.29 beat Zafgen's score of 0.00 indicating that Nuvation Bio is being referred to more favorably in the news media. Company Overall Sentiment Zafgen Neutral Nuvation Bio Neutral Is ZFGN or NUVB more profitable? Nuvation Bio's return on equity of -21.89% beat Zafgen's return on equity.Company Net Margins Return on Equity Return on Assets ZafgenN/A -51.34% -34.55% Nuvation Bio N/A -21.89%-17.86% Do institutionals and insiders believe in ZFGN or NUVB? 70.4% of Zafgen shares are held by institutional investors. Comparatively, 61.7% of Nuvation Bio shares are held by institutional investors. 14.2% of Zafgen shares are held by insiders. Comparatively, 5.1% of Nuvation Bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, ZFGN or NUVB? Zafgen is trading at a lower price-to-earnings ratio than Nuvation Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZafgenN/AN/A-$45.41M-$1.07-5.68Nuvation BioN/AN/A-$75.80M-$2.17-1.24 Does the MarketBeat Community believe in ZFGN or NUVB? Zafgen received 302 more outperform votes than Nuvation Bio when rated by MarketBeat users. However, 78.18% of users gave Nuvation Bio an outperform vote while only 68.59% of users gave Zafgen an outperform vote. CompanyUnderperformOutperformZafgenOutperform Votes34568.59% Underperform Votes15831.41% Nuvation BioOutperform Votes4378.18% Underperform Votes1221.82% Which has more volatility and risk, ZFGN or NUVB? Zafgen has a beta of 0.27, meaning that its stock price is 73% less volatile than the S&P 500. Comparatively, Nuvation Bio has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. SummaryNuvation Bio beats Zafgen on 10 of the 15 factors compared between the two stocks. Ad Porter & CompanyFinancial Prophecy The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.Including the name of the #1 company to buy. Get Zafgen News Delivered to You Automatically Sign up to receive the latest news and ratings for ZFGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZFGN vs. The Competition Export to ExcelMetricZafgenPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$227.82M$6.58B$5.14B$8.84BDividend YieldN/A8.11%5.05%4.07%P/E Ratio-6.3310.93132.3717.61Price / SalesN/A363.851,231.9986.52Price / CashN/A52.5940.0636.27Price / Book4.5010.176.956.36Net Income-$45.41M$153.36M$119.48M$226.00M Zafgen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZFGNZafgenN/A$6.08-4.7%N/A+93.9%$227.82MN/A-6.3338NUVBNuvation Bio2.3668 of 5 stars$2.70+4.7%$6.60+144.4%+91.5%$908.74MN/A-1.2460High Trading VolumeAVBPArriVent BioPharma1.0036 of 5 stars$26.59-3.0%$36.80+38.4%N/A$896.08MN/A0.0040ETNB89bio1.5073 of 5 stars$8.38+5.0%$30.33+262.0%+3.1%$889.37MN/A-2.8840CAPRCapricor Therapeutics3.8466 of 5 stars$17.93-5.2%$34.50+92.4%+537.0%$860.29M$23.23M-16.92N/AAnalyst RevisionLQDALiquidia3.7734 of 5 stars$10.15+0.3%$24.00+136.5%+55.7%$859.10M$17.49M-6.2150Analyst RevisionEOLSEvolus4.0317 of 5 stars$13.09+3.6%$23.00+75.8%+28.4%$828.59M$202.09M-14.36170Positive NewsRAPPRapport Therapeutics1.6863 of 5 stars$22.52+1.5%$35.00+55.4%N/A$823.78MN/A0.00N/ANews CoverageABCLAbCellera Biologics3.0263 of 5 stars$2.72+1.9%$8.67+218.6%-42.0%$803.41M$38.03M-4.46586Positive NewsPCRXPacira BioSciences4.008 of 5 stars$17.38+2.1%$23.50+35.2%-38.5%$802.44M$674.98M-8.56720Positive NewsPLRXPliant Therapeutics3.513 of 5 stars$12.85+0.9%$40.57+215.7%-11.4%$781.92M$1.58M-3.8590 Related Companies and Tools Related Companies NUVB Alternatives AVBP Alternatives ETNB Alternatives CAPR Alternatives LQDA Alternatives EOLS Alternatives RAPP Alternatives ABCL Alternatives PCRX Alternatives PLRX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ZFGN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zafgen Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zafgen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
